Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.
Saved in:
| Title: | Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models. |
|---|---|
| Authors: | Pierini S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Gabbasov R; Carisma Therapeutics Inc, Philadelphia, PA, USA., Oliveira-Nunes MC; Carisma Therapeutics Inc, Philadelphia, PA, USA., Qureshi R; Carisma Therapeutics Inc, Philadelphia, PA, USA., Worth A; Carisma Therapeutics Inc, Philadelphia, PA, USA., Huang S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Nagar K; Carisma Therapeutics Inc, Philadelphia, PA, USA., Griffin C; Carisma Therapeutics Inc, Philadelphia, PA, USA., Lian L; Carisma Therapeutics Inc, Philadelphia, PA, USA., Yashiro-Ohtani Y; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ross K; Carisma Therapeutics Inc, Philadelphia, PA, USA., Sloas C; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ball M; Carisma Therapeutics Inc, Philadelphia, PA, USA., Schott B; Carisma Therapeutics Inc, Philadelphia, PA, USA., Sonawane P; Carisma Therapeutics Inc, Philadelphia, PA, USA., Cornell L; Carisma Therapeutics Inc, Philadelphia, PA, USA., Blumenthal D; Carisma Therapeutics Inc, Philadelphia, PA, USA., Chhum S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Minutolo N; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ciccaglione K; Carisma Therapeutics Inc, Philadelphia, PA, USA., Shaw L; Carisma Therapeutics Inc, Philadelphia, PA, USA., Zentner I; Carisma Therapeutics Inc, Philadelphia, PA, USA., Levitsky H; Carisma Therapeutics Inc, Philadelphia, PA, USA., Shestova O; Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Gill S; Center for Cellular Immunotherapies, Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Varghese B; Carisma Therapeutics Inc, Philadelphia, PA, USA., Cushing D; Carisma Therapeutics Inc, Philadelphia, PA, USA., Ceeraz DeLong S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Abramson S; Carisma Therapeutics Inc, Philadelphia, PA, USA., Condamine T; Carisma Therapeutics Inc, Philadelphia, PA, USA., Klichinsky M; Carisma Therapeutics Inc, Philadelphia, PA, USA. michael.klichinsky@carismatx.com. |
| Source: | Nature communications [Nat Commun] 2025 Mar 19; Vol. 16 (1), pp. 2692. Date of Electronic Publication: 2025 Mar 19. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-57496-0 |
